Polydex Pharmaceuticals (POLXF) Stock Highlights

1.99 | +0.51%

2023-09-07 09:56:53

Polydex Pharmaceuticals Ltd is engaged in the development, manufacturing, and marketing of biotechnology-based products for the human pharmaceutical market. In addition, it also engaged in the manufacture and sale of veterinary pharmaceutical products and specialty chemicals. It focuses on the manufacture and sale of Dextran and derivative products, including Iron Dextran and Dextran Sulphate, and other specialty chemicals. Geographically sale of the products can be seen amplifying in the region of Europe, United States, Canada, and other countries of which the United States region accounts for the larger share of revenue.

Statistics

Range Today

1.99 1.99

Volume Today 2.09K

Range 1 Year

0.55 2.01

Volume 1 Year 1.09M

Range 3 Year

0.55 2.01

Volume 3 Year 1.76M

Range 10 Year

0.55 2.82

Volume 10 Year 6.32M

Highlights

Market Capitalization 6.82M (micro)

Current Price 1.99

Performance

Latest +0.51%

1 Month -1%

3 Months +6.42%

6 Months +206.15%

1 Year +176.39%

3 Years +131.4%

5 Years +91.35%

10 Years +134.12%

Benchmarks

Market Capitalization

354 / 368

Gross Profits

144 / 278

Total Revenue

0 / 300

Total Rank

229 / 368

Free Cashflow

0 / 352

Performance 5 years

61 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.